Skip to main content
ZEOX
OTC Life Sciences

CEO Ian Bothwell Discloses 40.2% Voting Control in Zeo ScientifiX

Analysis by Arik Shkolnikov
Sentiment info
Neutral
Importance info
8
Price
$2.304
Mkt Cap
$17.92M
52W Low
$1.2
52W High
$3.32
Market data snapshot near publication time

summarizeSummary

Zeo ScientifiX CEO Ian T. Bothwell updated his beneficial ownership, now holding 14.7% of common stock and an additional 25.5% of voting power through preferred stock, totaling 40.2% of the company's voting power.


check_boxKey Events

  • Significant Voting Control

    CEO Ian T. Bothwell now beneficially owns 14.7% of the common stock and an additional 25.5% of voting power through Series C Preferred Stock, resulting in an aggregate 40.2% of the company's total voting power.

  • Increased Common Stock Holdings

    His beneficial ownership of common stock increased to 1,195,094 shares, including 87,500 restricted shares vesting July 14, 2026, 187,500 shares from warrants, and 180,000 shares from options.

  • Equity Grants Reported

    The increase in common stock holdings since the last filing is primarily due to a grant of 55,000 stock options on May 8, 2025, and 175,000 restricted shares on January 14, 2026, both at a $0.00 price.


auto_awesomeAnalysis

This Schedule 13D/A filing updates the beneficial ownership of CEO, CFO, and Director Ian T. Bothwell, revealing he now controls a substantial 40.2% of the company's total voting power. This level of concentrated insider control is a critical factor for investors, as it grants significant influence over corporate decisions and strategic direction. The increase in his common stock holdings since the last filing is primarily due to recent compensation grants.

At the time of this filing, ZEOX was trading at $2.30 on OTC in the Life Sciences sector, with a market capitalization of approximately $17.9M. The 52-week trading range was $1.20 to $3.32. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed ZEOX - Latest Insights

ZEOX
May 15, 2026, 6:00 AM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
ZEOX
May 12, 2026, 10:09 AM EDT
Filing Type: 8-K
Importance Score:
9
ZEOX
May 12, 2026, 7:00 AM EDT
Source: Access Newswire
Importance Score:
8
ZEOX
Apr 21, 2026, 7:30 AM EDT
Filing Type: 8-K
Importance Score:
7
ZEOX
Apr 09, 2026, 7:16 AM EDT
Filing Type: 8-K
Importance Score:
8
ZEOX
Apr 07, 2026, 7:50 AM EDT
Filing Type: 8-K
Importance Score:
8
ZEOX
Mar 31, 2026, 8:15 AM EDT
Filing Type: 8-K
Importance Score:
7
ZEOX
Mar 27, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
ZEOX
Mar 17, 2026, 4:17 PM EDT
Filing Type: 10-Q
Importance Score:
8
ZEOX
Feb 06, 2026, 6:54 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
9